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Background: Computational methods have been widely used for the prediction of protein subcellular localization.
However, these predictions are rarely validated experimentally and as a result remain questionable. Therefore,
experimental validation of the predicted localizations is needed to assess the accuracy of predictions so that such
methods can be confidently used to annotate the proteins of unknown localization. Previously, we published a
method called ngLOC that predicts the localization of proteins targeted to ten different subcellular organelles. In
this short report, we describe the accuracy of these predictions using experimental validations.
Findings: We have experimentally validated the predicted subcellular localizations of 114 human proteins corresponding
to nine different organelles in normal breast and breast cancer cell lines using live cell imaging/confocal microscopy.
Target genes were cloned into expression vectors as GFP fusions and cotransfected with RFP-tagged organelle-specific
gene marker into normal breast epithelial and breast cancer cell lines. Subcellular localization of each target
protein is confirmed by colocalization with a co-expressed organelle-specific protein marker. Our results showed that
about 82.5% of the predicted subcellular localizations coincided with the experimentally validated localizations. The
highest agreement was found in the endoplasmic reticulum proteins, while the cytoplasmic location showed the least
concordance. With the exclusion of cytoplasmic location, the average prediction accuracy increased to 90.4%. In addition,
there was no difference observed in the protein subcellular localization between normal and cancer breast cell lines.
Conclusions: The experimentally validated accuracy of ngLOC method with (82.5%) or without cytoplasmic location
(90.4%) nears the prediction accuracy of 89%. These results demonstrate that the ngLOC method can be very useful for
large-scale annotation of the unknown subcellular localization of proteins.
Keywords: Protein subcellular localization, ngLOC prediction, Gene cloning, Experimental validation, GFP fusion, Live cell
imaging/confocal microscopyFindings
Background
Subcellular localization of proteins to specific compart-
ments is fundamental to the structural organization and
functioning of all living cells. Proteins that are localized to
unintended organelles have been implicated in the devel-
opment of many human diseases; therefore, knowledge
of the protein subcellular localization can benefit target
identification in the drug discovery process [1].
Protein subcellular localization is an important attribute
of protein function; thus, prediction of the same aids in* Correspondence: babu.guda@unmc.edu
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unless otherwise stated.genome annotation of high-throughput studies. Numerous
computational methods have been used for the prediction
of proteins subcellular localization [2]. Among these, some
are limited by predicting only a small number of organelles
in the cell [3,4] while some others exhibit lack of a balance
between sensitivity and specificity [5,6]. Previously, we
have developed a method called ngLOC, an n-gram
based Bayesian method that can predict a wide range of
subcellular locations including multiple localizations of
proteins [7,8]. This method makes its predictions solely
based on the protein sequence information without the
need for any extraneous information; therefore ngLOC
is highly favorable for proteome-wide prediction of sub-
cellular localizations.
The ngLOC method predicts subcellular locations at a
high overall accuracy of 89%, while the accuracy is muchtral. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and
iginal work is properly credited. The Creative Commons Public Domain
g/publicdomain/zero/1.0/) applies to the data made available in this article,
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as lysosomes, peroxisomes, Golgi, etc., [7] that are typically
difficult to predict due to lack of sufficient size datasets.
Although computational predictions provide wealth of in-
formation for the subcellular localization of proteins, these
predictions remain questionable unless they are validated
by experimental methods. In the present study, we report
experimental validations for ngLOC predicted subcellular
localizations of human proteins. Our results corroborated
the predicted results; thus ngLOC method can be used for
proteome-wide annotation of protein localizations.
Materials and methods
Reagents and materials
Restriction enzymes and DH5α-competent cells were pur-
chased from New England Biolabs (MA, USA). Trizol™,
transfection reagent Lipofectamine2000TM, and red fluor-
escent tagged-subcellular markers including Mitotracker™
Red FM, Lysotracker™ Red, ER-Tracker™ Red, BODIPY®
TR ceramide, Hoechst 33342 and Alexa Fluor® 594 WGA
were obtained from Invitrogen (CA, USA). A cDNA syn-
thesis and ligation kit was purchased from Promega (WI,
USA). Primers of all cloned genes for the PCR amplifica-
tion were obtained from Integrated DNA Technologies
Inc. (Coralville, IA). A 2X PCR amplification kit was pur-
chased from Applied Biological Materials Inc. (Richmond,
Canada). Plasmid and DNA gel extraction kits were
obtained from Qiagen Inc. (Valencia, CA). Fluorodish
35 mm petriplates for live cell imaging were purchased
from World Precision Instruments (Sarasota, FL). All
plastic wares for mammalian cell culture were pur-
chased from Corning Costar Corp. (NY, USA).
Plasmids and constructs
pEGFP-N1 vector was kindly provided by Dr. Hamid
Band (UNMC). Ten GFP-tagged full-length human
gene constructs (ngLOC predicted), which include:
SACM1L, ST13, TUBAL3, USMG5, DECR2, AMY2B,
UXS1, LGMN, NR2F1 and NAPB were obtained from
Origene Technologies Inc. (Rockville, MD). Six RFP-tagged
subcellular specific human gene constructs (positive
markers) which include: endoplasmic reticulum specific
ETS, Golgi specific TGOLN, peroxisome specific PXPM2,
mitochondria specific PDHA1, plasma membrane specific
LCK and cytoskeleton specific β-ACTIN were also pur-
chased from Origene Technologies Inc. (Rockville, MD).
Isolation of RNA and cDNA preparation
Total RNA was extracted from HEK-293 T cells using the
TRIzol™ method according to the manufacturer’s instruc-
tions. RNA quantity and purity were determined by UV
spectrophotometry and by electrophoresis on a 2% agarose
gel. Two micrograms of RNA was then reverse transcribed
using random hexamer primers and the superscript RTenzyme according to the manufacturer’s instructions
(Invitrogen, CA).
PCR amplification and gene cloning
PCR Amplification was achieved with the 2X PCR master
mix kit containing Taq DNA polymerase using 30–35
cycles according to the manufacturer’s protocols. For
amplification, the two sets of primers with appropriate
restriction enzymes were used against full-length ORF
of each human gene. The primers used for the genes
cloning of this study have been tabulated in Additional
file 1. Each PCR amplified gene product was separated
on 1% agarose gel in 1X TAE buffer (pH 8.0) and visu-
alized by ethidium bromide staining. The gel extraction
of PCR amplified gene products were purified using a gel
extraction kit; then these purified genes products were
double digested with restriction enzymes using the combin-
ation of either NheI/XhoI, NheI/HindIII or BglII/BamHI.
Following restriction digestions, the full-length genes were
cloned into a pEGFP-N1 vector using a LigaFast ligation kit
and were transformed into E. coli (DH5α) bacterial strain.
The positive clones of the genes were screened and con-
firmed, following appropriate restriction digestion.
Cell lines and culture conditions
The normal breast epithelial cell lines MCF-10A and
MCF-12 F were obtained from the American Type of
Culture Collection (Rockville, MD). These cell lines were
maintained in D-media described previously [9]. The breast
cancer epithelial cell lines MCF-7 and MDA-MB-231 were
kindly provided by Dr. Vimla band (UNMC). These cells
were cultured in α-MEM media supplemented with 10%
FBS (Invitrogen, CA), 2 mM glutamine (Invitrogen, CA),
50 μg/ml gentamicin (Invitrogen CA), 1x sodium pyruvate
(Invitrogen CA), 1x MEM non-essential amino acid
(Invitrogen, CA), 1x HEPES (Invitrogen, CA) and 1 μg/ml
insulin (Sigma). The cultures were maintained in a humidi-
fied incubator adjusted at 5% CO2 and 95% air atmosphere
at 37°C. All cultures were passaged twice a week and main-
tained at a concentration no greater than 1 × 106/ml.
Transient transfections and confocal microscopy
Breast normal (MCF-10A, MCF-12 F) and cancer (MCF-7,
MDA-MB-231) epithelial cells were seeded on 35-mm
fluorodish petriplates to reach approximately 50-70% con-
fluence in their respective medium. The next day, cells
were transiently co-transfected with 1 μg of GFP-tagged
predicted target gene and subcellular specific RFP-tagged
marker gene (endoplasmic reticulum specific ETS, Golgi
specific TGOLN, peroxisome specific PXPM2, mitochon-
dria specific PDHA1, plasma membrane specific LCK and
cytoskeleton specific β-ACTIN) for each of the localiza-
tions, using Lipofectamine in serum free MEM medium.
After 6–8 hours of transfection incubation, cells were
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another 12 hours of incubation for the protein expression.
Following protein expression, subcellular distribution and
co-localization of proteins were assessed under the con-
focal microscope. Alternatively, other red fluorescent
subcellular specific markers (dye) were also used with live
cells to validate the each localization. Each predicted
localization was confirmed and validated when the co-
localization produces a yellow color upon merging the
images of specific subcellular markers. Nuclear stain
Hoechst-33342 (1 μg/ml) was added to live cells for the
visualization of nucleus. Fluorescence images of live cells
were recorded through Zeiss LSM 710 confocal microscope
(Jena, Germany) with 40X objective lens. Images were cap-
tured and analyzed with LSM software (Jena, Germany)
and processed using standard software programs.
Results and discussion
The research strategy used for experimental validation
of ngLOC predicted protein subcellular localizations is
described in Figure 1. cDNA was synthesized from HEK-
293 T cells; with the use of cDNA, the genes of 105 target
proteins of human origin were PCR amplified and then
cloned into a GFP expression vector (pEGFP-N1) with
GFP at the N-terminus as a fusion gene. Using the ngLOC
method, 114 target proteins with predicted subcellularFigure 1 The cartoon shows the research strategy used to experimen
Genes of interest were cloned into pEGP-N1 vector as GFP fusions. These GFP
gene markers, were transiently co-transfected using liposome-mediated meth
of transfection and protein expression, subcellular localization was determined
compartment were confirmed by observing the colocalization of GFP- an
and red images.localization (includes 105 locally cloned and nine com-
mercially obtained) were selected for this validation study
(Additional file 2). GFP expressing fusion genes along with
corresponding location-specific RFP-tagged protein markers,
were transiently co-expressed following gene transfection
into two normal breast (MCF-10A, MCF-12 F) and two
breast cancer (MCF-7, MDA-231) cell lines; then their
subcellular localization was determined using live cell
imaging/confocal microscopy. In the present study, nine
different subcellular compartments were selected for val-
idating the predicted subcellular localization of proteins.
The images in Figure 2 show a representation of validated
localizations for predicted proteins in each compartment.
The localizations for each compartment (except for nu-
cleus and cytoplasm) were determined by observing the
colocalization of GFP- and RFP-tagged proteins, which
produced a yellow color upon merging the images. For
the nucleus and cytoplasm, we used a nuclear (Hoechst)
stain to validate the protein subcellular localization in
either location (Figure 2).
Table 1 lists the prediction for each gene tested, along
with the outcome of the validation experiment. Similarly,
Figure 3 shows the number of tested and succeeded pro-
teins in the validation experiments. Our live cell imaging
results showed that overall about 82.5% (94 out of 114)
of proteins validated in this study agreed with the ngLOCtally validate the predicted subcellular localization of proteins.
-tagged genes along with corresponding location-specific RFP-tagged
od into two normal breast and breast cancer cell lines. Following 24 hours
using live cell imaging/confocal microscopy. Protein localizations to each
d RFP-tagged proteins that gives yellow color up on merging green
Figure 2 Experimental validation of predicted localization of human proteins. GFP-tagged full-length genes of target proteins and RFP-tagged
compartment specific genes were transiently co-expressed in two normal and two breast cancer cell lines. Subcellular localization of the transiently
expressed proteins was determined under the confocal microscope (40X). To facilitate the visualization of predicted subcellular localization, the specific
RFP-tagged protein marker/dye for each localization was used in colocalization studies. Hoechst (nuclear dye) was used in all experiments. This figure
shows a representative observation of colocalization in MCF-7 cells for each of the nine subcellular compartments used for validation in this study.
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four cell lines tested. However, with the exclusion of the
cytoplasm location that shows the lowest accuracy (45%),
the average prediction rate increases to 90.4% (85 out of
94). ngLOC method outputs the predictions in a ranked
order by using the associated confidence score (probability)
for each location. The top two locations can be predicted
within a close confidence range, suggesting that either or
both of the predictions can be true. It is known that a
number of proteins are localized to multiple organelles in
eukaryotic cells (7). To test the accuracy of the second
choice we also validated the second predictions of 30
proteins, which included 17 proteins (Set I) whose first
choice predictions were proven wrong and 13 proteins
(Set II) whose first choice predictions were accurate in
the above experiments. From Set I, 10 proteins have
shown homogenous distribution in cells, suggesting their
localization both in the cytoplasm and nucleus (Table 2).
For seven of these 10 proteins, the top two ngLOC predic-
tions were cytoplasm or nucleus, which support our resultsthat these proteins are localized in both nucleus and
cytoplasm. From the other 7 proteins in Set I, the second
choice predictions were validated as correct only for 2
proteins (Table 2). Validation results on Set II showed that
about 46% (6 out of 13) of the proteins tested have also
agreed with the second prediction (Table 2), indicating
that these proteins are dual localized. With the inclusion
of the second prediction validations, we have experimen-
tally validated the subcellular localization of 144 ngLOC
predictions.
We also looked into the correlation between the confi-
dence score (CS) and prediction accuracy for ngLOC pre-
dictions. CS is expressed as percentage and the value can
range from zero to 100. ngLOC method uses a minimum
CS of 20 to make predictions (7), however we chose only a
small subset of predicted proteins for validation. The CS
for validated proteins ranges from 20 to 73 in this study.
We divided the total number of validated proteins into
two groups, low CS group (CS <46) and high CS group
(CS >46); where, CS of 46 is the midpoint of the CS range
Table 1 Experimental validation for ngLOC predicted
proteins subcellular localization
Protein Prediction Validation Protein Prediction Validation
NR2F1 NUC Yes FKBP7 END Yes
LMO2 NUC Yes ZFAN2B END Yes
LEF1 NUC Yes USMG5 MIT Yes
U2AF1L4 NUC No UQCR10 MIT Yes
KLF7 NUC Yes COX6B1 MIT Yes
PHF5A NUC No BRP44L MIT Yes
LMO1 NUC Yes UCP3 MIT Yes
HMNG4 NUC Yes SFXN1 MIT Yes
SCNM1 NUC Yes NDUFS8 MIT Yes
SNRNP27 NUC Yes ATP5S MIT Yes
SSX3 NUC Yes COX7C MIT Yes
LMO1 NUC Yes MRPL30 MIT Yes
PRKRIP1 NUC Yes MRPL15 MIT Yes
HNRNPCL1 NUC Yes PHB MIT Yes
MAB21L1 NUC Yes MRPL53 MIT No
VGLL2 NUC Yes MRPS24 MIT Yes
AES NUC Yes MRPL10 MIT Yes
ST13 CYT Yes MRPL2 MIT Yes
MLST8 CYT Yes COX7B MIT Yes
GNPDA2 CYT Yes MRPL51 MIT No
CARD17 CYT No MRP63 MIT Yes
RAC1 CYT No COQ9 MIT Yes
FKBP1B CYT Yes LGMN LYS Yes
SPRR2F CYT Yes CTSL2 LYS Yes
SPRR2G CYT Yes MMD LYS Yes
NUD10 CYT Yes RAB7A LYS Yes
PCTP CYT No ITM2C LYS Yes
PEBP1 CYT No DECR2 POX Yes
RPL36AL CYT No ZADH2 POX Yes
GST5A CYT No PXMP4 POX Yes
OTUB1 CYT Yes TUBAL3 CSK Yes
PCMT1 CYT No TMSB15A CSK No
PGPEP1 CYT No DYNLL2 CSK No
PGEP1-2 CYT No ACTBL2 CSK Yes
PMP2 CYT No CAPZB CSK Yes
PPIAL4A CYT No TMSB4Y CSK No
UBE2K CYT Yes CAPZA1 CSK Yes
UXS1 GOL Yes ANKRA2 CSK Yes
UGCG GOL Yes PDLIM1 CSK Yes
GKAP1 GOL Yes TRIM54 CSK Yes
HS2ST1 GOL Yes PNP CSK Yes
GKAP1-2 GOL Yes CDC42EP5 CSK Yes
GCNT2 GOL Yes SEP3 CSK Yes
Table 1 Experimental validation for ngLOC predicted
proteins subcellular localization (Continued)
GABRAPL2 GOL No ACTRT3 CSK Yes
ZADHHC3 GOL Yes NABP PLA Yes
ST6SIA1 GOL Yes GNAS PLA Yes
SACM1L END Yes KCNIP2 PLA Yes
SEC11A END Yes MOG PLA Yes
SEC11C END Yes CD8B PLA Yes
CNPY3 END Yes CACNG4 PLA Yes
CNPY3-2 END Yes IFITM2 PLA No
SEC61G END Yes STOML3 PLA Yes
DGAT2 END Yes RTP1 PLA Yes
ASPH END Yes ABHD6 PLA Yes
MEST END Yes RASD2 PLA Yes
DOLPP1 END Yes TMEM68 PLA Yes
POFUT1 END Yes RHOV PLA Yes
Chaturvedi et al. BMC Research Notes 2014, 7:912 Page 5 of 7
http://www.biomedcentral.com/1756-0500/7/912for the proteins validated. Our validation results showed
that 88% (50 out of 57) of the low CS group proteins were
predicted accurately, compared to that of the high CS
group proteins, which was 77% (44 out of 57). While these
results are counter-intuitive, the high CS group contains a
number of proteins that are predicted to be localized to
cytoplasm, which has the highest false positive rate. With-
out counting the cytoplasmic proteins, the accuracies
would be 92% for low CS group and 89% for the high
CS group. These results demonstrate that there is no
significant correlation between the CS and prediction
accuracy. We presume that the lack of correlation is due
to the unbalanced selection of validated proteins from a
narrow range of confidence scores (see Additional file 3:
Table S1), which in turn is due to feasibility (project costs
limiting the sample size) and technical (PCR amplification
of longer genes) issues that limited our ability to select
proteins from a wider CS range for validation.Figure 3 Graph showing the total number of tested and those
that are in agreement with the predicted localizations in each
subcellular location. This graph was generated based on the data
provided in Table 1.
Table 2 Experimental validation of ngLOC top second










U2AF1L4 NUC CYT * *
CARD17 CYT NUC * *
RAC1 CYT PLA No No
PCTP CYT NUC * *
PEBP1 CYT PLA No No
RPL36AL CYT NUC * *
GST5A CYT NUC * *
PCMT CYT NUC * *
PGPEP1 CYT NUC * *
PMP2 CYT NUC * *
PPIAL4A CYT MIT No Yes
GABRAPL2 GOL CSK No Yes
MRPL51 MIT CYT No No
MRPL53 MIT CYT No No
DYNLL2 CSK NUC * *
TMSB4Y CSK CYT * *
TMSB15A CSK NUC * *
PXMP4 POX PLA Yes No
MMD LYS PLA Yes No
RAB7A LYS PLA Yes No
SEC61G END MIT Yes Yes
DGAT2 END PLA Yes No
DOLPP1 END PLA Yes Yes
SEC11A END PLA Yes No
CNPY3 END PLA Yes No
LMO1 NUC MIT Yes Yes
LMO2 NUC PLA Yes Yes
NUDT10 CYT PLA Yes No
CDC42EP5 CSK PLA Yes Yes
ZDHHC3 GOL PLA Yes Yes
The asterisk (*) represents homogenous distribution where localization of
protein was seen in both cytoplasm and nucleus.
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localized to ER (33-65%), lysosomal (38-50%) and per-
oxisomal (23-39%), the validation accuracy is 100% at
these locations. Similarly, plasma membrane, cytoskeletal,
mitochondrial, Golgi and nuclear proteins recorded about
85% accuracy (Figure 3). Conversely, cytoplasmic proteins
scored the lowest with only 45% prediction accuracy. The
high false positives in this location can be attributed to
the fact that cytoplasm location, being the default loca-
tion for protein synthesis, lacks specific targeting sig-
nals that makes it difficult to predict. Another reason
could be the dual- or multi-localization of about one-thirdof cytoplasmic proteins to other locations (7); where, the
machine learning methods face difficulty in discriminating
the cytoplasmic proteins compared to those from other
locations.
Overall, the experimental validations in this study prove
that the ngLOC method can predict the subcellular
localization of proteins at an accuracy of 82.5%, contrary
to the reported accuracy of 89% (7). However, with the ex-
clusion of the low performing cytoplasmic location (45%),
the average accuracy rate jumped to 90.4% (85 out of 94).
As shown in Figure 3, the accuracy is especially notable
for the locations with smaller proteomes (ER, Golgi, Lyso-
some and Peroxisome), which are typically difficult to
predict by machine learning methods. These results
demonstrate the robustness, accuracy, and application
in annotating the unknown subcellular localization of pro-
teomes of eukaryotic species using the ngLOC method.
Conclusion
This study experimentally validates and reports the accur-
acy of a computational method called ngLOC that predicts
the subcellular localization of protein sequences in
eukaryotic cells. We validated 114 human proteins that
were predicted to be localized to nine distinct subcellular
locations in eukaryotic cells. The overall validation accur-
acy rate of ngLOC method is at 82.5%, while the rate
improved to 90.4% just by excluding the cytoplasmic lo-
cation, compared to the overall prediction accuracy of
89%. Thus, this validation study demonstrates that
ngLOC can be reliably used (with the exception of cyto-
plasmic location) to annotate the subcellular localization
of proteins and affirms the utility of this method in large-
scale annotation of newly sequenced proteomes.
Additional files
Additional file 1: Primer list with the restriction sites used for gene
cloning.
Additional file 2: Predictions by ngLOC method for proteins
without a known subcellular localization.
Additional file 3: Table S1. Statistics showing the spread and range of
confidence scores (CS) in the predicted and validated proteins in each
subcellular location.
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